✦ LIBER ✦

Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

✍ Scribed by M. Prete; F. Perosa; E. Favoino; F. Dammacco

Publisher: Springer
Year: 2005
Tongue: English
Weight: 251 KB
Volume: 5
Category: Article
ISSN: 0372-8722
DOI: 10.1007/s10238-005-0080-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A gene therapy approach to treatment of

A gene therapy approach to treatment of autoimmune disease

✍ Christine M. Seroogy; C. Garrison Fathman 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 930 KB

Successful anti-CD20 monoclonal antibody

Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency

✍ Mary Wakim; Ami Shah; Patricia A. Arndt; George Garratty; Kenneth Weinberg; Thom 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## Abstract Autoimmune hemolytic anemia due to warm reactive IgM autoantibodies is unusual, severe, and often fails to respond to standard immunosuppressive therapies in both adults and children. A 6‐year‐old girl with common variable immunodeficiency had longstanding steroid dependent, splenectomy

Initial treatment of acute graft-versus-

Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human α/β T cell receptor

✍ Dietrich W. Beelen; Hans Grosse-Wilde; Ursula Ryschka; Klaus Quabeck; Herbert G. 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 640 KB

Ofatumumab, a human anti-CD20 monoclonal

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

✍ Mikkel Østergaard; Bo Baslund; William Rigby; Bernadette Rojkovich; Christian Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views